Get the Stockscreener App
0.0227
65.39%
0.00896
Revive Therapeutics Ltd Stock (RVVTF) Forecast
The Revive Therapeutics Ltd (RVVTF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.8681, representing a +3,731% increase from the current price of $0.0227. The highest analyst price target is $0.9061, and the lowest is $0.83.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RVVTF Price Target
Average 0.9308
(+4,008% Upside)
Long-term RVVTF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Revive Therapeutics Ltd financial reports and earnings history, Revive Therapeutics Ltd (RVVTF) stock could reach $2.4971 by 2030, $8.0819 by 2040 and $5.8419 by 2050. See the projected annual prices until 2050 of the Revive Therapeutics Ltd stock below:
- Revive Therapeutics Ltd (RVVTF) is expected to reach an average price of $4.4444 in 2035, with a high prediction of $5.156 and a low estimate of $4.4757. This indicates an $19,515% rise from the last recorded price of $0.0227.
- Revive Therapeutics Ltd (RVVTF) stock is projected to chart a bullish course in 2040, with an average price target of $7.1615, representing an $31,507% surge from its current level. The forecast ranges from a conservative $7.1743 to a sky-high $8.0819.
- Our analysts predict Revive Therapeutics Ltd (RVVTF) to jump 45,099% by 2045, soaring from $3.5381 to an average price of $10.24, potentially reaching $10.88. While $3.5381 is the low estimate, the potential upside is significant.
- Revive Therapeutics Ltd (RVVTF) stock is expected to climb by 2050, reaching an average of $5.1048, a $22,430% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8419 and $4.3677, respectively, highlighting the market's uncertainty.
Revive Therapeutics Ltd Stock (RVVTF) Year by Year Forecast
Revive Therapeutics Ltd Stock (RVVTF) Price Forecast for 2025
Revive Therapeutics Ltd Stock (RVVTF) is expected to reach an average price of $0.7785 in 2025, with a high prediction of $1.2619 and a low estimate of $0.2951. This indicates an +3,336% rise from the last recorded price of $0.0227.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.809 | $0.83 | $0.9061 | +3,470% |
| June, 2025 | $0.6753 | $0.7006 | $0.7407 | +2,880% |
| July, 2025 | $0.5589 | $0.5717 | $0.6245 | +2,367% |
| August, 2025 | $0.4428 | $0.4507 | $0.4833 | +1,854% |
| September, 2025 | $1.2002 | $0.3705 | $1.2619 | +5,197% |
| October, 2025 | $1.0951 | $1.1078 | $1.1202 | +4,733% |
| November, 2025 | $0.8866 | $0.9177 | $1.0331 | +3,813% |
| December, 2025 | $0.776 | $0.7889 | $0.8462 | +3,325% |
Revive Therapeutics Ltd Stock (RVVTF) Price Forecast for 2026
The predicted value for Revive Therapeutics Ltd (RVVTF) in 2026 is set at an average of $1.083. Estimates vary from a peak of $1.7201 to a trough of $0.4459, indicating an +4,680% surge from the present price of $0.0227.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.5883 | $0.6078 | $0.7271 | +2,496% |
| February, 2026 | $0.4737 | $0.481 | $0.5303 | +1,991% |
| March, 2026 | $1.3684 | $0.4459 | $1.491 | +5,940% |
| April, 2026 | $1.1736 | $1.1946 | $1.3109 | +5,080% |
| May, 2026 | $1.0187 | $1.0867 | $1.092 | +4,396% |
| June, 2026 | $0.8033 | $0.8161 | $0.9387 | +3,445% |
| July, 2026 | $0.6337 | $0.6416 | $0.7143 | +2,697% |
| August, 2026 | $1.6451 | $0.5214 | $1.7201 | +7,160% |
| September, 2026 | $1.4864 | $1.4992 | $1.5516 | +6,460% |
| October, 2026 | $1.2246 | $1.2557 | $1.4111 | +5,305% |
| November, 2026 | $1.0471 | $1.06 | $1.1583 | +4,521% |
| December, 2026 | $0.8059 | $0.8254 | $0.9849 | +3,457% |
Revive Therapeutics Ltd Stock (RVVTF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Revive Therapeutics Ltd (RVVTF) is $1.3875, with a high forecast of $2.1783 and a low forecast of $0.5968. This indicates an +6,024% increase from the last price of $0.0227.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6379 | $0.6452 | $0.7346 | +2,715% |
| February, 2027 | $1.8274 | $0.5968 | $1.9492 | +7,965% |
| March, 2027 | $1.5383 | $1.5593 | $1.7156 | +6,689% |
| April, 2027 | $1.3299 | $1.416 | $1.4433 | +5,769% |
| May, 2027 | $1.0477 | $1.0605 | $1.2366 | +4,524% |
| June, 2027 | $0.8246 | $0.8325 | $0.9453 | +3,540% |
| July, 2027 | $2.1928 | $0.6722 | $2.1783 | +9,578% |
| August, 2027 | $1.8778 | $1.8906 | $2.0766 | +8,188% |
| September, 2027 | $1.5625 | $1.5936 | $1.7891 | +6,796% |
| October, 2027 | $1.3846 | $1.3966 | $1.4829 | +6,011% |
| November, 2027 | $1.0236 | $1.0431 | $1.3023 | +4,418% |
| December, 2027 | $0.8021 | $0.8094 | $0.9389 | +3,440% |
Revive Therapeutics Ltd Stock (RVVTF) Price Forecast for 2028
In 2028, Revive Therapeutics Ltd (RVVTF) is projected to reach an average price of $1.8066, with a high projection of $2.8656 and a low estimate of $0.7476. This indicates an +7,873% rise from the last price of $0.0227.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.2047 | $0.7476 | $2.4074 | +9,630% |
| February, 2028 | $1.9029 | $1.9239 | $2.1204 | +8,298% |
| March, 2028 | $1.6411 | $1.7272 | $1.7946 | +7,143% |
| April, 2028 | $1.3761 | $1.3874 | $1.5344 | +5,973% |
| May, 2028 | $1.0156 | $1.0235 | $1.2747 | +4,382% |
| June, 2028 | $2.651 | $0.823 | $2.6365 | +11,600% |
| July, 2028 | $2.2692 | $2.282 | $2.5214 | +9,915% |
| August, 2028 | $1.9004 | $1.9315 | $2.1671 | +8,287% |
| September, 2028 | $1.6691 | $1.6811 | $1.8075 | +7,266% |
| October, 2028 | $1.2413 | $1.2608 | $1.5734 | +5,378% |
| November, 2028 | $0.9663 | $0.9736 | $1.1432 | +4,165% |
| December, 2028 | $2.6903 | $0.8984 | $2.8656 | +11,774% |
Revive Therapeutics Ltd Stock (RVVTF) Price Forecast for 2029
The 2029 price forecast for Revive Therapeutics Ltd Stock (RVVTF) is $2.1488 on average, with a high prediction of $3.3238 and a low estimate of $0.9739. This represents an +9,384% increase from the previous price of $0.0227.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.2676 | $2.2886 | $2.5499 | +9,908% |
| February, 2029 | $1.9523 | $2.0384 | $2.1459 | +8,516% |
| March, 2029 | $1.6338 | $1.6451 | $1.8323 | +7,111% |
| April, 2029 | $1.2065 | $1.2144 | $1.519 | +5,225% |
| May, 2029 | $3.1092 | $0.9739 | $3.0947 | +13,622% |
| June, 2029 | $2.7356 | $2.7676 | $2.9663 | +11,973% |
| July, 2029 | $2.2383 | $2.2695 | $2.6309 | +9,779% |
| August, 2029 | $1.9536 | $1.9656 | $2.132 | +8,522% |
| September, 2029 | $1.5522 | $1.5786 | $1.8445 | +6,751% |
| October, 2029 | $1.1305 | $1.1378 | $1.4324 | +4,889% |
| November, 2029 | $3.1218 | $1.0493 | $3.3238 | +13,678% |
| December, 2029 | $2.6322 | $2.6532 | $2.968 | +11,517% |
Revive Therapeutics Ltd Stock (RVVTF) Price Forecast for 2030
Revive Therapeutics Ltd Stock (RVVTF) is expected to reach an average price of $2.4534 in 2030, with a high forecast of $3.782 and a low forecast of $1.1247. This signifies an +10,728% surge from the last price of $0.0227.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.2635 | $2.3496 | $2.4971 | +9,890% |
| February, 2030 | $1.8916 | $1.9029 | $2.1301 | +8,248% |
| March, 2030 | $1.5043 | $1.5166 | $1.7634 | +6,539% |
| April, 2030 | $3.5674 | $1.1247 | $3.5529 | +15,645% |
| May, 2030 | $3.1403 | $3.1723 | $3.4111 | +13,760% |
| June, 2030 | $2.688 | $2.7193 | $3.0222 | +11,763% |
| July, 2030 | $2.238 | $2.25 | $2.5484 | +9,777% |
| August, 2030 | $1.7833 | $1.8097 | $2.1156 | +7,770% |
| September, 2030 | $1.2947 | $1.302 | $1.6501 | +5,614% |
| October, 2030 | $3.5533 | $1.2001 | $3.782 | +15,582% |
| November, 2030 | $3.1158 | $3.1422 | $3.3861 | +13,651% |
| December, 2030 | $2.5747 | $2.6608 | $2.9859 | +11,263% |
0.41%
0.12%
Cap:
|
Volume (24h):